Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.22.1
Stockholders’ Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jan. 20, 2022
May 31, 2020
Mar. 31, 2022
Dec. 31, 2021
Mar. 18, 2022
Jan. 18, 2022
Stockholders’ Equity (Details) [Line Items]            
Restricted stock units (in Shares) 18,666          
Common stock shares issued     $ 12,196      
Accounts payable     $ 10,000      
Fair value price per share (in Dollars per share)     $ 0.82      
Common shares issued (in Shares)     11,395,650 11,293,030 71,758 71,758
Legal settlement.         $ 75,000 $ 75,000
Stockholders’ equity description   the Company received $515,000 of a committed $565,000 from the sale of 135,527 shares of common stock (at a price of $3.80 per share) and warrants to purchase 169,409 shares of common stock, at an exercise price of $4.00 per share. As of March 31, 2022, $415,000 worth of the shares and warrants have been issued.        
Equity financing     $ 125,000 $ 125,000    
Unrecognized expense     $ 1,100,000 $ 1,000,000    
Minimum [Member]            
Stockholders’ Equity (Details) [Line Items]            
Unrecognized expenses to be recognized, term     12 months      
Maximum [Member]            
Stockholders’ Equity (Details) [Line Items]            
Unrecognized expenses to be recognized, term     3 years      
Series A Convertible Preferred Stock [Member]            
Stockholders’ Equity (Details) [Line Items]            
Common shares (in Shares)     45,000,000      
Convertible preferred shares authorized (in Shares)     900,000      
Convertible preferred shares par value of per share (in Dollars per share)     $ 0.001